Home › Ziekte van Crohn › Californië › Los Angeles
Ziekte van Crohn klinische studies in Los Angeles, CA
15 studies voor Ziekte van Crohn zoeken deelnemers op locaties in en rond Los Angeles (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
RekruterenFase 3
- Cedars Sinai Medical Center ( Site 5080), Los Angeles
- UCLA Clinical & Translational Research Center (CTRC) ( Site 5116), Los Angeles
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
RekruterenFase 3
- Cedars Sinai Medical Center, Los Angeles
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
RekruterenFase 3
- TLC Clinical Research Inc, Los Angeles
- GastroIntestinal Bioscience, Los Angeles
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
RekruterenFase 2/3
- TLC Clinical Research Inc, Los Angeles
- GastroIntestinal Bioscience, Los Angeles
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RekruterenFase 3
- TLC Clinical Research Inc.-Site Number: 8400030, Los Angeles
- GastroIntestinal Bioscience - Los Angeles-Site Number: 8400019, Los Angeles
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
RekruterenFase 2
- Biopharma Informatic, LLC, Los Angeles
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
RekruterenFase 2
- Biopharma Informatic, LLC, Los Angeles
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
RekruterenFase 4
- Cedars-Sinai Medical Center, Los Angeles
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
RekruterenFase 3
- Cedars Sinai Medical Center, Los Angeles
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Rekruteren
- Cedars-Sinai, Los Angeles
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
RekruterenFase 3
- Keck Medicine Of USC - USC Healthcare Center 1, Los Angeles
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
RekruterenFase 4
- Cedars-Sinai, Los Angeles
Precise Infliximab Exposure and Pharmacodynamic Control
RekruterenFase 2/3
- Children's Hospital of Los Angeles, Los Angeles
Impact of Prebiotics in Ulcerative Colitis
Rekruteren
- UCLA, Los Angeles
Stem Cell Transplantation in Crohn's Disease
RekruterenFase 1/2
- Cedars-Sinai Medical Center, Los Angeles
Ziekte van Crohn studies in andere steden
- New York City, NY35 studies
- Boston, MA19 studies
- Miami, FL19 studies
- Cleveland, OH19 studies
- St. Louis, MO19 studies
- Tyler, TX17 studies
- Orlando, FL17 studies
- Houston, TX17 studies
- Atlanta, GA17 studies
- San Antonio, TX15 studies
- San Diego, CA15 studies
- Colorado Springs, CO13 studies
Andere studies in Los Angeles
- Niet-kleincellige longkanker87 studies
- Kanker (alle vormen)74 studies
- Borstkanker73 studies
- Prostaatkanker61 studies
- Colorectale kanker59 studies
- Metastatische kanker57 studies
- Eierstokkanker50 studies
- Longkanker45 studies
- Plaveiselcelcarcinoom van hoofd en hals42 studies
- Aldermeesklierkanker35 studies
- Endometriumkanker34 studies
- Melanoom34 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.